Establishment of a liver fibrosis model in cynomolgus monkeys

Experimental and Toxicologic Pathology

Volumn 66, Issue 5-6, 2014, Pages 257-261

  Ding, Ke ^a,b   Liu, Man Rong ^a   Li, Jianmin ^a   Huang, Ke ^a   Liang, Yi ^a   Shang, Xiaobin ^a   Chen, Jiong ^a   Mu, Jian ^a   Liu, Huimei ^b  

^a Second People's Hospital of Nanning   (China)

^b GUILIN MEDICAL UNIVERSITY   (China)

Author keywords

Carbon tetrachloride; Cynomolgus monkeys; Liver fibrosis model

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CARBON TETRACHLORIDE; COLLAGEN TYPE 4; GLOBULIN; HYALURONIC ACID; LAMININ; PROCOLLAGEN; PROTEIN; TYPE III PRECOLLAGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; HEPATITIS; HISTOPATHOLOGY; HUMAN VERSUS ANIMAL COMPARISON; LIVER BIOPSY; LIVER DYSFUNCTION; LIVER FIBROSIS; MACACA FASCICULARIS; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; STAGING; ANIMAL; BIOPSY; CHEMICALLY INDUCED; DRUG EFFECTS; ENZYMOLOGY; EXPERIMENTAL LIVER CIRRHOSIS; LIVER; LIVER CELL; LIVER FUNCTION TEST; PATHOLOGY; TOXICITY;

ANIMALS; BIOPSY; CARBON TETRACHLORIDE; DISEASE PROGRESSION; HEPATOCYTES; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; LIVER FUNCTION TESTS; MACACA FASCICULARIS; MALE;

EID: 84901000562     PISSN: 09402993     EISSN: 16181433     Source Type: Journal    
DOI: 10.1016/j.etp.2014.03.003     Document Type: Article

References (22)

1. 4 model of liver fibrosis in rats. Sci World J 2007, 7:1242-1255.
2. Chang M.L., Yeh C.T., Chang P.Y., Chen J.C. Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation. World J Gastroenterol 2005, 11(27):4167-4172.
3. Chinese Medical Association, Infectious and Parasitic Branch, Liver Disease Branch Programs for prevention and treatment of viral hepatitis. Chin J Infect Dis 2001, 19(1):56-62.
4. Chow A.M., Tan M, Gao D.S., Fan S.J., Cheung J.S., Qiao Z., et al. Molecular MRI of liver fibrosis by a peptide-targeted contrast agent in an experimental mouse model. Invest Radiol 2013, 48(1):46-54.
5. 4. Chongqing Med 2014, 43(4):456-458.
6. Fallowfield J.A., Iredale J.P. Reversal of liver fibrosis and cirrhosis-an emerging reality. Scott Med J 2004, 49(1):3-6.
7. Guo Y., Wang H., Zhang C. Establishment of rat precision-cut fibrotic liver slice technique and its application in verapamil metabolism. Clin Exp Pharmacol Physiol 2007, 34(5-6):406-413.
8. Guo R., Bai B. Advances in development of large animal models of liver fibrosis and cirrhosis. World Chin J Digestol 2013, 21(5):421-426.
9. Hung D.Y., Chang P., Cheung K., Winterford C., Roberts M.S. Quantitative evaluation of altered hepatic spaces and membrane transport in fibrotic rat liver. Hepatology 2002, 36(5):1180-1189.
10. Ismail M.H., Pinzani M. Reversal of liver fibrosis. Saudi J Gastroenterol 2009, 15(1):72-79.
11. Li Y., He J., Sun J. Study on biological parameters for Macaca Fascicularis in experiment. Mod Prev Med 2010, 37(13):2503-2505.
12. Liu H., Yu J., Ding K., Tan Y. The effect of propofol metabolism in Crab-Eating monkeys with hepatic fibrosis at different phases. J Pract Med 2012, 28(22):3700-3702.
13. Liu M.R., Ding K., Tang J., Tang Y., Ma Y. Comparison of simple and composite methods in induction of rabbit model of liver fibrosis induced by carbon tetrachloride. Med Front 2013, 3(2):83-84.
14. 4. Guangdong Med 2013, 34(4):525-527.
15. Liu P., Gao Y. Establishment of liver fibrosis animal model. World J Gastroenterol 2002, 10(6):693-695.
16. Pang R., Liu J., He J., Wang H., Zhang B., Wang H., et al. Establishment and evaluation of macaque liver fibrosis model. World Chin J Digestol 2005, 13(16):1956-1958.
17. Ramachandran P., Iredale J.P. Reversibility of liver fibrosis. Ann Hepatol 2009, 8(4):283-291.
18. Sato R., Maesawa C., Fujisawa K., Wada K., Oikawa K., Takikawa Y., et al. Prevention of critical telomere shortening by oestradiol in human normal hepatic cultured cells and carbon tetrachloride induced rat liver fibrosis. Gut 2004, 53(7):1001-1009.
19. Smyth R., Munday M.R., York M.J., Clarke C.J., Dare T., Turton J.A. Comprehensive characterization of serum clinical chemistry parameters and the identification of urinary superoxide dismutase in a carbon tetrachloride-induced model of hepatic fibrosis in the female Hanover Wistar rat. Int J Exp Pathol 2007, 88(5):361-376.
20. Wang L., Potter J.J., Rennie-Tankersley L., Novitskiy G., Sipes J., Mezey E. Effects of retinoic acid on the development of liver fibrosis produced by carbon tetrachloride in mice. Biochim Biophys Acta 2007, 1772(1):66-71.
21. Zhang H., Wen T., Lu J., Li S., Wang J., Piao Z. Investigation of induction of rat model of liver injury induced by carbon tetrachloride. J Clin Hepatol 2009, 12(3):161-163.
22. Zhuang H. Strengthening prevention and control of hepatitis B Beijing University. Health Sci 2009, 41(3):259-262.